Molecule intelOpportunity: ModerateEssentialCrowded market

Simvastatin

239 brands · 110 companies · product forms

ATC: C10AA01

Opportunity snapshot

Launch attractiveness
35
Market saturation
100
Price room
100
Regulatory risk
0
239
brands
110
companies
Rs 382.46
median price
234
price points
12.31x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 132.43
MedianRs 382.46
Most expensiveRs 1,630.86
Spread12.31×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 12.31x across 234 trusted points (Rs 132.43-1630.86). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Simvastatin — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

110 canonical companies and 239 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 12.31x across 234 trusted points (Rs 132.43-1630.86). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.